Fleet Bioprocessing attending London Life Sciences Week 2026
Fleet Bioprocessing will be attending London Life Sciences Week, running across London from 15–20 November 2026.
The week brings together organisations from across biotechnology, pharmaceuticals, healthcare, research and investment through a programme of conferences, networking events, showcases and meetings taking place across the capital.
For Fleet, it provides an opportunity to connect with companies developing new diagnostics, therapeutics and life science technologies and to discuss where specialist outsourced development support can complement internal R&D capabilities.
The themes are closely aligned with our work at Fleet Bioprocessing. We provide contract support for Immunoassay Development, Lateral Flow Assay Development and Bioconjugation, together with Complementary Services including Protein Purification, Formulation, Dispensing and Lyophilisation. Our teams can support projects from early feasibility and critical reagent work through assay optimisation, performance verification and transfer to manufacture. Fleet is ISO 9001 and ISO 13485 certified.
Alastair Dent FRSC will be attending the event. With four decades of experience in process development and manufacture, Alastair Dent FRSC brings extensive technical and commercial knowledge across diagnostic assay development, bioconjugation, experimental design, GMP and the development of robust processes for manufacture.
As Fleet Bioprocessing’s Managing Director & Quality Director, Alastair works closely with companies looking to solve development challenges, access specialist expertise or add additional technical capacity to their programmes.
If you will be in London during London Life Sciences Week and would like to discuss a current or upcoming development programme, Alastair would be pleased to arrange a meeting.
You can also get in touch with us here:
